Ironwood Pharmaceuticals Initiates Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (IBS-C Pharmaceutical Investing
CytoDyn Announces Positive Results from Completed Pivotal PRO 140 HIV Combination Trial Biotech Investing
NanoSphere Health Sciences’ Brand Evolve Formulas Partners with Former NHL Star Jeff Friesen Cannabis Investing News
Advaxis Announces FDA Lifts Clinical Hold on Phase 1/2 Combination Study of Axalimogene Filolisbac with Durvalumab Biotech Investing
